Biofilm-forming pathogens like Staphylococcus aureus often induce immune suppression, allowing them to evade host defenses and persist in chronic infections. This immune suppression involves reduced phagocytic activity, downregulated cytokine production, and impaired activation of immune cells. In contrast, immune activation or stimulation aims to restore and enhance the host’s immune response against biofilm-associated bacteria. Strategies to overcome this suppression include the use of immunomodulatory agents, peptides, or nanoparticles that boost innate and adaptive immunity, promote cytokine release, and enhance the clearance of biofilm-embedded bacteria, thereby improving treatment outcomes.

More Sarita Maurya's questions See All
Similar questions and discussions